Research
Clinical outcome trials study the use of human monoclonal antibodies to target biochemical pathways that impact LDL receptor availability and monoclonal antibodies to block the PCSK-9 protein.
Molecular autopsy employs genetic testing to understand the cause of sudden death and better predict risk for surviving family members.
New Mayo Clinic research supports catheter ablation versus medical therapy alone for atrial fibrillation in patients with heart failure.
A baseline of vascular health established during early perimenopause can serve as a marker to measure effectiveness of lifestyle changes aimed at prevention of, as well as clinical treatment for, cardiovascular disease.
|